Skip to main content
Home
FULL MENU Close Menu
Home
Home

Nancy A. Melville

News

Schizophrenia patients in long-term facilities benefit from lower-dose antipsychotics

Author:
Nancy A. Melville
Publish date: June 8, 2022

With careful monitoring, some with severe schizophrenia show improved stabilization, social engagement after their long-acting antipsychotic doses...

  • Read More

News

Surgical site infections not increased in immunocompromised patients after Mohs surgery

Author:
Nancy A. Melville
Publish date: June 6, 2022

Mohs surgery is increasingly being performed for patients who are immunosuppressed because of their higher incidence of skin cancer and higher...

  • Read More

News

Mohs surgery in the elderly: The dilemma of when to treat

Author:
Nancy A. Melville
Publish date: June 6, 2022

“The take-home point for me is to treat your whole patient, not just the tumor.”

  • Read More

News

High-dose antipsychotics show some benefit in treatment-resistant cases

Author:
Nancy A. Melville
Publish date: June 3, 2022

Patients with severe schizophrenia show decreases in severity and hospitalizations with notably few side effects; but some say stick with...

  • Read More

News

Psilocybin benefits in severe depression observed up to 12 weeks

Author:
Nancy A. Melville
Publish date: June 1, 2022

A synthetic psilocybin shows sustained improvements after a single dose/session in the largest randomized controlled trial of its kind.

  • Read More

News

Studies address ibrutinib bleeding risk in patients with CLL receiving Mohs surgery

Author:
Nancy A. Melville
Publish date: May 31, 2022

Mohs surgeons may commonly find themselves treating patients with these unique considerations.

  • Read More

News

Long COVID neuropsychiatric deficits greater than expected

Author:
Nancy A. Melville
Publish date: May 31, 2022

Studies document the cognitive and psychiatric effects of long COVID.

  • Read More

News

Depressed patients respond faster to IV ketamine than intranasal ketamine

Author:
Nancy A. Melville
Publish date: May 26, 2022

One of the first comparator studies shows responses with fewer treatments for depression with IV versus intranasal ketamine.

  • Read More

News

Lithium lowers osteoporosis risk in bipolar patients…and orthopedists take notice

Author:
Nancy A. Melville
Publish date: May 25, 2022

Patients with bipolar disorder treated with lithium show significant reductions in osteoporosis, suggesting a protective effect on bone loss.

  • Read More

News

Topical tranexamic acid reduces postop bleeding following Mohs surgery

Author:
Nancy A. Melville
Publish date: May 25, 2022

“No studies have evaluated topical TXA with the aim to reduce postoperative bleeding in the setting of Mohs micrographic surgery,” one of the...

  • Read More

News

Bupivacaine following Mohs surgery reduces opioid use, study finds

Author:
Nancy A. Melville
Publish date: May 19, 2022

Recent research has shown that Mohs micrographic surgeons have the highest rates of opioid prescribing of all dermatologists.

  • Read More

News

Keeping thyroid hormone treatment on target is key for the heart

Author:
Nancy A. Melville
Publish date: May 18, 2022

‘Both undertreatment and overtreatment were associated with adverse cardiovascular outcomes,’ including higher mortality, but keeping thyroid...

  • Read More

News

Polypectomy clipping success is based on anticoagulant type

Author:
Nancy A. Melville
Publish date: May 13, 2022

The removal of polyps has a high risk of hemorrhage, and the use of antithrombotic medications are well established as key risk factors for the...

  • Read More

News

Obesity interactions complex in acute pancreatitis

Author:
Nancy A. Melville
Publish date: May 10, 2022

Severity scores based on body mass index alone do not accurately predict disease severity in patients with acute pancreatitis.

  • Read More

News

‘Agony of choice’ for clinicians treating leukemia

Author:
Nancy A. Melville
Publish date: May 10, 2022

Novel targeted therapies emerge as frontline options while chemoimmunotherapy “fades into the background.”

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2023 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close